BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31327041)

  • 21. Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: long-term results of a prospective trial (National Clinical Trial 00254683).
    Perez RO; Habr-Gama A; Gama-Rodrigues J; Proscurshim I; Julião GP; Lynn P; Ono CR; Campos FG; Silva e Sousa AH; Imperiale AR; Nahas SC; Buchpiguel CA
    Cancer; 2012 Jul; 118(14):3501-11. PubMed ID: 22086847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Semiquantitative Volumetry by Sequential PET/CT May Improve Prediction of Complete Response to Neoadjuvant Chemoradiation in Patients With Distal Rectal Cancer.
    Dos Anjos DA; Perez RO; Habr-Gama A; São Julião GP; Vailati BB; Fernandez LM; de Sousa JB; Buchpiguel CA
    Dis Colon Rectum; 2016 Sep; 59(9):805-12. PubMed ID: 27505108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of readout-segmented echo-planar imaging-based diffusion-weighted imaging in evaluating tumor response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Yang L; Xia C; Liu D; Fang X; Pan X; Ma L; Wu B
    Acta Radiol; 2020 Sep; 61(9):1155-1164. PubMed ID: 31924105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy.
    Napoletano M; Mazzucca D; Prosperi E; Aisa MC; Lupattelli M; Aristei C; Scialpi M
    Abdom Radiol (NY); 2019 Nov; 44(11):3664-3673. PubMed ID: 31004202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of percent change in tumoral volume measured at T
    Quaia E; Gennari AG; Ricciardi MC; Ulcigrai V; Angileri R; Cova MA
    J Magn Reson Imaging; 2016 Dec; 44(6):1415-1424. PubMed ID: 27219471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET/MRI and PET/CT hybrid imaging of rectal cancer - description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study.
    Rutegård MK; Båtsman M; Axelsson J; Brynolfsson P; Brännström F; Rutegård J; Ljuslinder I; Blomqvist L; Palmqvist R; Rutegård M; Riklund K
    Cancer Imaging; 2019 Jul; 19(1):52. PubMed ID: 31337428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations.
    Sahani DV; Kalva SP; Hamberg LM; Hahn PF; Willett CG; Saini S; Mueller PR; Lee TY
    Radiology; 2005 Mar; 234(3):785-92. PubMed ID: 15734934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study protocol: multi-parametric magnetic resonance imaging for therapeutic response prediction in rectal cancer.
    Pham TT; Liney G; Wong K; Rai R; Lee M; Moses D; Henderson C; Lin M; Shin JS; Barton MB
    BMC Cancer; 2017 Jul; 17(1):465. PubMed ID: 28676107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of lymph node metastasis on rectal cancer by PET-CT computer imaging combined with MRI technology.
    Li F; Hu J; Jiang H; Sun Y
    J Infect Public Health; 2020 Sep; 13(9):1347-1353. PubMed ID: 31289005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of sequential 18(F) -FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer.
    Sun W; Xu J; Hu W; Zhang Z; Shen W
    Colorectal Dis; 2013 May; 15(5):e231-8. PubMed ID: 23384167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.
    Giganti F; De Cobelli F; Canevari C; Orsenigo E; Gallivanone F; Esposito A; Castiglioni I; Ambrosi A; Albarello L; Mazza E; Gianolli L; Staudacher C; Del Maschio A
    J Magn Reson Imaging; 2014 Nov; 40(5):1147-57. PubMed ID: 24214734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery.
    Capirci C; Rubello D; Pasini F; Galeotti F; Bianchini E; Del Favero G; Panzavolta R; Crepaldi G; Rampin L; Facci E; Gava M; Banti E; Marano G
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1461-9. PubMed ID: 19419820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Textural Parameters of Tumor Heterogeneity in ¹⁸F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer.
    Bundschuh RA; Dinges J; Neumann L; Seyfried M; Zsótér N; Papp L; Rosenberg R; Becker K; Astner ST; Henninger M; Herrmann K; Ziegler SI; Schwaiger M; Essler M
    J Nucl Med; 2014 Jun; 55(6):891-7. PubMed ID: 24752672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment.
    Aker M; Boone D; Chandramohan A; Sizer B; Motson R; Arulampalam T
    Abdom Radiol (NY); 2018 Dec; 43(12):3213-3219. PubMed ID: 29767284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET.
    Capirci C; Rubello D; Chierichetti F; Crepaldi G; Carpi A; Nicolini A; Mandoliti G; Polico C
    Biomed Pharmacother; 2004 Oct; 58(8):451-7. PubMed ID: 15464875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodal Assessments Are Needed for Restaging after Neoadjunvant Chemoradiation Therapy in Rectal Cancer Patients.
    Kye BH; Kim HJ; Kim G; Kim JG; Cho HM
    Cancer Res Treat; 2016 Apr; 48(2):561-6. PubMed ID: 26323642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer.
    Bang JI; Ha S; Kang SB; Lee KW; Lee HS; Kim JS; Oh HK; Lee HY; Kim SE
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):422-31. PubMed ID: 26338180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease.
    Barbaro B; Leccisotti L; Vecchio FM; Di Matteo M; Serra T; Salsano M; Poscia A; Coco C; Persiani R; Alfieri S; Gambacorta MA; Valentini V; Giordano A; Bonomo L
    Br J Radiol; 2017 Jan; 90(1069):20150836. PubMed ID: 27845566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MAGNETIC RESONANCE IMAGING TO EVALUATE NEOADJUVANT THERAPY EFFECTS ON RECTAL CARCINOMA.
    Sofić A; Vukobrat-Bijedić Z; Husić-Selimović A; Šehović N; Buija D; Eminagić D; Banjin M; Đuran A
    Acta Clin Croat; 2015 Sep; 54(3):303-8. PubMed ID: 26666099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stage and size using magnetic resonance imaging and endosonography in neoadjuvantly-treated rectal cancer.
    Swartling T; Kälebo P; Derwinger K; Gustavsson B; Kurlberg G
    World J Gastroenterol; 2013 Jun; 19(21):3263-71. PubMed ID: 23745028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.